Free Trial

Coppell Advisory Solutions LLC Buys 6,337 Shares of Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

  • Coppell Advisory Solutions LLC increased its stake in Procter & Gamble by 28.3%, acquiring an additional 6,337 shares to reach a total of 28,764 shares, worth approximately $4.67 million.
  • CEO Gary A. Coombe and Jon R. Moeller both sold significant portions of their shares recently, decreasing their holdings by 22.57% and 11.16% respectively.
  • Procter & Gamble announced a quarterly dividend of $1.0568 per share, reflecting a 2.6% dividend yield and a payout ratio of 64.98%.
  • Interested in Procter & Gamble? Here are five stocks we like better.

Coppell Advisory Solutions LLC lifted its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 28.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 28,764 shares of the company's stock after purchasing an additional 6,337 shares during the quarter. Coppell Advisory Solutions LLC's holdings in Procter & Gamble were worth $4,667,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Capital A Wealth Management LLC bought a new position in shares of Procter & Gamble during the 4th quarter valued at about $31,000. Quarry LP purchased a new stake in Procter & Gamble during the 1st quarter valued at about $33,000. 10Elms LLP purchased a new stake in Procter & Gamble during the 4th quarter valued at about $34,000. Sunbeam Capital Management LLC purchased a new stake in Procter & Gamble during the 4th quarter valued at about $34,000. Finally, Mizuho Securities Co. Ltd. boosted its holdings in Procter & Gamble by 566.7% during the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after acquiring an additional 170 shares during the period. 65.77% of the stock is currently owned by institutional investors.

Insider Transactions at Procter & Gamble

In other news, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares of the company's stock, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jon R. Moeller sold 40,119 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the transaction, the chief executive officer directly owned 319,375 shares of the company's stock, valued at $50,228,106.25. This represents a 11.16% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is owned by insiders.

Procter & Gamble Trading Up 0.6%

NYSE PG opened at $160.08 on Monday. Procter & Gamble Company has a fifty-two week low of $149.91 and a fifty-two week high of $180.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The stock has a 50 day simple moving average of $156.41 and a two-hundred day simple moving average of $162.21. The stock has a market cap of $374.65 billion, a P/E ratio of 24.59, a price-to-earnings-growth ratio of 4.22 and a beta of 0.36.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the prior year, the company earned $1.40 EPS. The business's revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a $1.0568 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.6%. Procter & Gamble's dividend payout ratio is currently 64.98%.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on PG. Evercore ISI restated an "in-line" rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. BNP Paribas restated an "outperform" rating and set a $177.00 target price on shares of Procter & Gamble in a report on Friday, August 15th. Barclays set a $164.00 target price on Procter & Gamble and gave the company an "equal weight" rating in a report on Thursday, July 31st. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Finally, Wells Fargo & Company dropped their price objective on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the company's stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of "Moderate Buy" and an average price target of $175.12.

View Our Latest Report on Procter & Gamble

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Forget Earnings Hype: 2 Must-Buy Stocks and 2 to Dump
AMD’s 2026 Forecasts Are Way Too Low
Massive Data Week Could Rock Markets — Here Are the Top Plays

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines